Hepatotoxicity of 5-azacytidine (NSC-102816) (a clinical and pathologic study).
D000208:Acute Disease; D000328:Adult; D000368:Aged; D001374:Azacitidine / Q000009:adverse effects / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D003562:Cytidine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007728:Kupffer Cells / Q000187:drug effects; D008099:Liver / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D014227:Triazines / Q000009:adverse effects*
D014227:Triazines; D003562:Cytidine; D001374:Azacitidine